US Federal 2025-2026 Regular Session

US Federal Senate Bill SB4446

Introduced
4/30/26  

Caption

PRESS Act Preventing Rogue Equipment for Synthetic Substances Act

Impact

If enacted, SB4446 would have significant implications for the regulation of controlled substances, particularly focusing on enhancing the legal framework surrounding the manufacturing and distribution of equipment used in drug production. The bill specifically makes it illegal for individuals or companies to manufacture or distribute tableting machines and similar equipment with the knowledge or intent that these items would be used unlawfully. This change is expected to bolster law enforcement efforts in combating drug trafficking and counterfeit drug production by creating more robust legal mechanisms to target those who facilitate such activities.

Summary

SB4446, also known as the Preventing Rogue Equipment for Synthetic Substances Act (PRESS Act), seeks to amend the Controlled Substances Act with the primary objective of preventing the importation of illicit pill press machines that can be used to counterfeit substances. The bill aims to establish stricter regulations regarding the manufacturing and distribution of machinery intended for the unlawful production of controlled substances. By broadening the scope of unlawful activities, the legislation addresses a gap in current laws that could be exploited by those aiming to produce counterfeit pharmaceuticals.

Contention

There are notable points of contention surrounding SB4446, particularly regarding the balance between regulation and the potential for overreach. Some stakeholders argue that the bill is crucial in combating the surge of counterfeit drugs that pose significant health risks to the public. Conversely, others express concern about the implications of broad regulatory measures, fearing that they could inadvertently affect legitimate businesses that utilize these machines for lawful purposes. The discourse surrounding the bill highlights the ongoing challenges of creating effective drug laws that effectively target illegal activities without stifling legitimate industry operations.

Companion Bills

US HB7184

Related PRESS Act Preventing Rogue Equipment for Synthetic Substances Act

Previously Filed As

US HB7184

PRESS Act Preventing Rogue Equipment for Synthetic Substances Act

US SB2318

Illicit synthetic substances; provide felony for the delivery of, where subsequent use of the substance results in death.

US SB938

Joint Task Force to Counter Illicit Synthetic Narcotics Act of 2025

US HB2024

Joint Task Force to Counter Illicit Synthetic Narcotics Act of 2025

US HB5880

Fight Illicit Pill Presses Act

US SB2870

Fight Illicit Pill Presses Act

US HB1100

STOPP Act Stop the Opioid Pill Presser and Fentanyl Act

US HB0113

AN ACT to amend Tennessee Code Annotated, Section 39-17-402, relative to testing equipment used to determine the presence of a synthetic opioid.

US SB1290

AN ACT to amend Tennessee Code Annotated, Section 39-17-402, relative to testing equipment used to determine the presence of a synthetic opioid.

US H0309

Controlled Substances

Similar Bills

US SB331

HALT Fentanyl Act Halt All Lethal Trafficking of Fentanyl Act

US HB830

SAFE Act Save Americans from the Fentanyl Emergency Act

US HB27

HALT Fentanyl Act Halt All Lethal Trafficking of Fentanyl Act

US SB3228

SIMSA Act of 2025 Stop the Importation and Manufacturing of Synthetic Analogues Act of 2025

US HB7019

Campus Prevention and Recovery Services for Students Act of 2026

IA SF328

A bill for an act relating to controlled substances, including certain controlled substances schedules and precursor substances reporting requirements, making penalties applicable, and including effective date provisions.

IA HF2202

A bill for an act relating to controlled substances schedules and precursor substances reporting requirements, making penalties applicable, and including effective date provisions. (Formerly HSB 528.) Effective date: 04/16/2026.

IA SSB3035

A bill for an act relating to controlled substances schedules and precursor substances reporting requirements, making penalties applicable, and including effective date provisions.(See SF 2281.)